This article relies largely or entirely on a single source. (June 2019) |
| Clinical data | |
|---|---|
| Other names | 2,4,5-Triethoxyamphetamine |
| Routes of administration | Oral[1] |
| ATC code |
|
| Pharmacokinetic data | |
| Duration of action | Unknown[1] |
| Identifiers | |
| |
| CAS Number | |
| PubChem CID |
|
| ChemSpider | |
| UNII |
|
| CompTox Dashboard (EPA) |
|
| Chemical and physical data | |
| Formula | C15H25NO3 |
| Molar mass | 267.369 g·mol−1 |
| 3D model (JSmol) |
|
| |
| (verify) | |
EEE, also known as 2,4,5-triethoxyamphetamine, is a drug.[1] It is the triethoxy analogue of TMA-2.[1] EEE was first synthesized by Alexander Shulgin.[1] In his book PiHKAL, both the dose and duration are unknown..[1] EEE produces few to no effects.[1] Very little data exists about the pharmacological properties, metabolism, and toxicity of EEE.[1]
See also
References
- ^ a b c d e f g h Shulgin AT, Shulgin A (1991). "EEE". PiHKAL: A Chemical Love Story (1st ed.). Berkeley, CA: Transform Press. ISBN 978-0-9630096-0-9. OL 22859055M.